1. Berenblum, J. (1974). Carcinogenesis as a Biological Problem. (New York: Elsevier)
2. Bergquist, C., Nillius, S. J. and Wide, L. (1979a). Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent. Lancet, 2, 215
3. Bergquist, C., Nillius, S. J. and Wide, L. (1979b). Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist. Contraception, 19, 497
4. Bergquist, C., Nillius, S. J. and Wide, L. (1982). Peptide contraception in women. Xth World Congress of Gynecology and Obstetrics, San Francisco, Abstract 1148
5. Canales, E. S., Montvelinsky, H., Fonseca, E., Zárate, A., Coy, D. and Schally, A. V. (1980). The use of a potent stimulatory LHRH analog (D-Trp-6-LHRH) in the induction of ovulation. Int. J. Fertil., 25, 193